Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation

Simona Sica, C. Martínez, C. Canals, B. Sarina, E. P. Alessandrino, D. Karakasis, A. Pulsoni, M. Trneny, J. A. Snowden, E. Kanfer, N. Milpied, A. Bosi, S. Guidi, C. A. De Souza, R. Willemze, R. Arranz, L. Jebavy, A. Hellmann, D. Sibon, R. OnetoJ. J. Luan, P. Dreger, L. Castagna, A. Sureda

Risultato della ricerca: Contributo in rivistaArticolo in rivista

72 Citazioni (Scopus)

Abstract

High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard of care for patients with relapsed Hodgkin's lymphoma (HL). However, there is currently little information on the predictors of outcome for patients whose disease recurs after ASCT.
Lingua originaleEnglish
pagine (da-a)2430-2434
Numero di pagine5
RivistaAnnals of oncology : official journal of the European Society for Medical Oncology / ESMO
Volume24
DOI
Stato di pubblicazionePubblicato - 2013

Keywords

  • Hodgkin's lymphoma
  • autologous stem cell transplantation
  • relapse

Fingerprint

Entra nei temi di ricerca di 'Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation'. Insieme formano una fingerprint unica.

Cita questo